z-logo
open-access-imgOpen Access
S t. J ohn's W ort Reduces Beta‐Amyloid Accumulation in a Double Transgenic A lzheimer's Disease Mouse Model—Role of P ‐Glycoprotein
Author(s) -
Brenn Anja,
Grube Markus,
Jedlitschky Gabriele,
Fischer Andrea,
Strohmeier Barbara,
Eiden Martin,
Keller Markus,
Groschup Martin H.,
Vogelgesang Silke
Publication year - 2014
Publication title -
brain pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.986
H-Index - 132
eISSN - 1750-3639
pISSN - 1015-6305
DOI - 10.1111/bpa.12069
Subject(s) - hypericum perforatum , hyperforin , genetically modified mouse , amyloid precursor protein , p glycoprotein , pharmacology , transgene , glycoprotein , chemistry , amyloid (mycology) , medicine , microbiology and biotechnology , alzheimer's disease , biochemistry , biology , disease , gene , pathology , multiple drug resistance , antibiotics
The adenosine triphosphate‐binding cassette transport protein P ‐glycoprotein ( ABCB1 ) is involved in the export of beta‐amyloid from the brain into the blood, and there is evidence that age‐associated deficits in cerebral P ‐glycoprotein content may be involved in A lzheimer's disease pathogenesis. P ‐glycoprotein function and expression can be pharmacologically induced by a variety of compounds including extracts of H ypericum perforatum ( S t. J ohn's W ort). To clarify the effect of S t. J ohn's W ort on the accumulation of beta‐amyloid and P ‐glycoprotein expression in the brain, S t. J ohn's W ort extract (final hyperforin concentration 5%) was fed to 30‐day‐old male C57BL/6J ‐ APP /PS1 +/− mice over a period of 60 or 120 days, respectively. Age‐matched male C57BL/6J ‐ APP / PS1 +/− mice receiving a S t. J ohn's W ort‐free diet served as controls. Mice receiving S t. J ohn's W ort extract showed (i) significant reductions of parenchymal beta‐amyloid 1–40 and 1–42 accumulation; and (ii) moderate, but statistically significant increases in cerebrovascular P ‐glycoprotein expression. Thus, the induction of cerebrovascular P ‐glycoprotein may be a novel therapeutic strategy to protect the brain from beta‐amyloid accumulation, and thereby impede the progression of A lzheimer's disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom